Preparation and characterization of chitosan microparticles intended for controlled drug delivery.
about
Preparation, characterization, and potential application of chitosan, chitosan derivatives, and chitosan metal nanoparticles in pharmaceutical drug deliveryPreparation of various metal-silicate micro-balloons using W/O/W emulsion.Controlled drug delivery systems based on thiolated chitosan microspheres.Preparation of recombinant human bone morphogenetic protein-2 loaded dextran-based microspheres and their characteristics.Effect of drying processes and curing time of chitosan-lysine semi-IPN beads on chlorpheniramine maleate delivery.In vitro and in vivo studies on chitosan beads of losartan Duolite AP143 complex, optimized by using statistical experimental design.Bioresponsive Materials for Drug Delivery Based on Carboxymethyl Chitosan/Poly(γ-Glutamic Acid) Composite MicroparticlesExperimental and mathematical studies on the drug release properties of aspirin loaded chitosan nanoparticles.Chitosan-carboxymethyl tamarind kernel powder interpolymer complexation: investigations for colon drug deliveryStability, Intracellular Delivery, and Release of siRNA from Chitosan Nanoparticles Using Different Cross-Linkers.Synergetic effects of doxycycline-loaded chitosan nanoparticles for improving drug delivery and efficacy.Transfection of mEpo gene to intestinal epithelium in vivo mediated by oral delivery of chitosan-DNA nanoparticles.Applying the Taguchi design for optimized formulation of sustained release gliclazide chitosan beads: an in vitro/in vivo studyChitosan-based nanoparticles for improved anticancer efficacy and bioavailability of mifepristone.Controlling chitosan-based encapsulation for protein and vaccine delivery.Chitosan-Based Multifunctional Platforms for Local Delivery of Therapeutics.Marine polysaccharides in pharmaceutical applications: an overviewProduction methodologies of polymeric and hydrogel particles for drug delivery applications.Chitosan nanoparticles in drug therapy of infectious and inflammatory diseases.The development of non-toxic ionic-crosslinked chitosan-based microspheres as carriers for the controlled release of silk sericin.Microparticles to enhance delivery of drugs and growth factors into wound sites.Evaluation of Chitosan-Tripolyphosphate Nanoparticles as a p-shRNA Delivery Vector: Formulation, Optimization and Cellular Uptake Study.Ionic Cross-linked Chitosan Beads for Extended Release of Ciprofloxacin: In vitro Characterization.Screening of ionically crosslinked chitosan-tripolyphosphate microspheres using Plackett-Burman factorial design for the treatment of intrapocket infections.Formulation, optimization and characterization of cationic polymeric nanoparticles of mast cell stabilizing agent using the Box-Behnken experimental design.Lyophilized sustained release mucoadhesive chitosan sponges for buccal buspirone hydrochloride delivery: formulation and in vitro evaluation.Polyethylene glycol on stability of chitosan microparticulate carrier for protein.Microencapsulation of Probiotics by Calcium Alginate-gelatinized Starch with Chitosan Coating and Evaluation of Survival in Simulated Human Gastro-intestinal ConditionAn approach for lacidipine loaded gastroretentive formulation prepared by different methods for gastroparesis in diabetic patients.Evaluation of ionotropic cross-linked chitosan/gelatin B microspheres of tramadol hydrochloride.Chitosan/polyethylene glycol beads crosslinked with tripolyphosphate and glutaraldehyde for gastrointestinal drug delivery.pH-Triggered Magnetic-Chitosan Nanogels (MCNs) For Doxorubicin Delivery: Physically vs. Chemically Cross Linking Approach.Poly(lactic-co-glycolic) acid/nanohydroxyapatite scaffold containing chitosan microspheres with adrenomedullin delivery for modulation activity of osteoblasts and vascular endothelial cells.Two-stage optimization process for formulation of chitosan microspheresChitosan microspheres of aceclofenac: in vitro and in vivo evaluation.Formulation and Evaluation of Controlled Release Floating Microballoons of Stavudine.Chitosan nanoparticles as a new delivery system for the chemotherapy agent tegafur.Optimization of physicochemical parameters influencing the fabrication of protein-loaded chitosan nanoparticles.Curcumin-containing chitosan nanoparticles as a potential mucoadhesive delivery system to the colon.Nano drug delivery systems and gamma radiation sterilization.
P2860
Q26766552-D624DD1A-BACC-486E-9832-103240EBAC05Q30793803-23EE2ED2-B914-4BB9-AC42-F495D6EBA7F3Q33221961-766A44D1-B090-4C90-9FF8-84A10F3B7AE2Q33222092-B36F3863-D048-4CF2-AA14-98D222555D68Q33349937-E7403EA2-49EE-454F-9791-81444AD2451AQ33573427-A39E8C44-B616-4DF5-BEC3-4F9B901F785FQ33744113-8604BEAE-B911-40D5-A12A-71BF595D8176Q33760050-92605873-F09A-4403-A0A9-5DB592F26283Q34410031-38388542-8327-49D0-A212-4D55F86E8CC7Q35661857-379534CC-FE24-4858-9C45-E128CE9F7297Q36088815-5C3AEA08-FCC5-488F-A973-B6B1412768A5Q36474541-53F8B791-2AC5-4E94-8CA6-9558401E0E24Q37146176-C0D29B50-03A5-4BC7-B399-BBD944B4CB28Q37587889-540BEB6E-B673-4262-B5CB-BA83C8E8807DQ37684382-1EBA76F5-1CA1-4195-9D71-E9F20A16324BQ37721800-CE3BB71C-2884-42DF-BE4E-55A7D895EE0AQ37800376-8E9E3013-F7BD-4251-8B31-ABBC51BF0E71Q37976414-8B724F04-8838-418B-839A-5D4683C3CE6DQ38810516-8D3701C0-004C-4F59-87F3-A7F9FCC3B537Q38847309-8D282EB7-A8D4-4D38-A84C-C7F463160988Q38993469-CECF4A6B-4C76-4954-B24C-F8A15A8C0412Q39011082-5AB6BA94-16B5-4A9A-96C6-1D56B18AD40CQ39962791-EA843540-1B9F-409B-AAFD-F843E7EE69E3Q40148926-F7B5435F-E437-4D53-895D-CD93B1895D5EQ40331959-1B0EF2AB-3311-41F5-86F6-A2D38041FCD0Q41110148-D5382F71-DF0A-43E4-92D5-4FA0591DA6C6Q41778625-377021EE-A45C-4792-8C3D-EFDDFE44CD66Q41778966-B50AF4A0-F397-4B3C-A3D3-2A850E9245FBQ41852480-5E887C67-53DD-4620-8F11-5CB0210E75B1Q41870433-7F919383-1696-4821-AB0F-C628287B915EQ41988794-FC194DA3-1748-4946-ABFC-D753DE84668DQ42087700-CCE5442A-8464-44ED-A81E-23997E001196Q42182010-065C4498-601B-44FB-8D37-CC0DE544BA59Q42678713-6ABEBAAE-425C-4B8D-9921-6F1126A92EEDQ42927551-4D508274-A600-4811-A6F0-E85754B3C3EBQ43067198-DC16677D-B750-4774-B355-67A917F4F892Q43117560-AEFF155B-242D-4622-8D3C-FD50BF2B6187Q43259026-A10E757B-69D6-4913-B479-2C0ABC477D8CQ43942247-38AF9C3B-CA63-4774-86D9-541729CC90CCQ44623438-FF3CBB6B-CD76-4216-8280-024760C1EDA4
P2860
Preparation and characterization of chitosan microparticles intended for controlled drug delivery.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Preparation and characterizati ...... for controlled drug delivery.
@en
Preparation and characterizati ...... for controlled drug delivery.
@nl
type
label
Preparation and characterizati ...... for controlled drug delivery.
@en
Preparation and characterizati ...... for controlled drug delivery.
@nl
prefLabel
Preparation and characterizati ...... for controlled drug delivery.
@en
Preparation and characterizati ...... for controlled drug delivery.
@nl
P2093
P1476
Preparation and characterizati ...... for controlled drug delivery.
@en
P2093
P304
P356
10.1016/S0378-5173(02)00487-8
P407
P577
2002-12-01T00:00:00Z